期刊文献+

2型糖尿病患者血清hsCRP、TNF-α及IL-6的表达及相关性分析 被引量:2

Correlation Analysis and Expression of hsCRP,TNF-α and IL-6 in the Serum of Type 2 Diabetic
下载PDF
导出
摘要 目的分析高敏C反应蛋白(CRP)、肿瘤坏死因子-α(TNF-α)、白细胞介素-6(IL-6)在2型糖尿病患者血清的表达及相关性,探讨它们在2型糖尿病发病过程中的作用及意义。方法分别测定32例健康人群(对照组)和32例2型糖尿病患者(实验组)血清hsCRP、TNF-α、IL-6水平,并采用SPSS13.0软件对实验数据进行统计分析。结果对照组hsCRP、TNF-α、IL-6的血清浓度值明显低于实验组,两者之间的差异十分显著(P=0.000)。实验组hsCRP、TNF-α、IL-6三者之间存在明显相关性。结论hsCRP、TNF-α、IL-6在2型糖尿病患者血清中明显增高且存在明显相关。提示三者可能参与了2型糖尿病的发病过程,其检测对2型糖尿病的诊断和预后具有潜在的临床价值。 Objective To analyze the expression and the correlation of high sensitivity C-reactive protein (hsCRP),tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6) in the serum of the patients with type 2 diabetic and explore the clinical significance in the diagnosis and prognosis of type 2 diabetic. Methods The expression level of hsCRP and TNF-α and IL-6 in the serum samples from 32 healthy people who were as control group and 32 type 2 diabetic patients who were as experimental group were detected. The data was analyzed by using the SPSS 12.0 software. Results The concentration of hsCRP and TNF-α and IL-6 in the control group was obvious lower than that of the experimental group. There was statistics significance between the two groups (P=0.000). The expression levels of hsCRP and TNF-αand IL-6 of the serum showed close correlation with each other in the experimental group. Conclusion The expression level of hsCRP and TNF-α and IL-6 in the serum of type 2 diabetic patients were not only higher than them in the serum of health people,but demonstrated positive correlation with each other. The results show that hsCRP and TNF-α and IL-6 may be involved in the pathogenesis of type 2 diabetic,and maybe have potential clinical values in the diagnosis and prognosis of type 2 diabetic.
出处 《贵州医药》 CAS 2008年第12期1076-1078,共3页 Guizhou Medical Journal
基金 贵州省优秀科技教育人才省长专项资金项目[黔省专合字(2005)25号]
关键词 高敏C反应蛋白 肿瘤坏死因子-A 白细胞介素-6 2型糖尿病 High sensitivity C-reactive protein Tumor necrosis factor-alpha Interleukin-6 Type 2 diabetic
  • 相关文献

参考文献5

  • 1T. Tanaka,H. Itoh,K. Doi,Y. Fukunaga,K. Hosoda,M. Shintani,J. Yamashita,T.-H. Chun,M. Inoue,K. Masatsugu,N. Sawada,T. Saito,G. Inoue,H. Nishimura,Y. Yoshimasa,K. Nakao.Down regulation of peroxisome proliferator-activated receptorγ expression by inflammatory cytokines and its reversal by thiazolidinediones[J].Diabetologia.1999(6)
  • 2J. C. Pickup,M. B. Mattock,G. D. Chusney,D. Burt.NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X[J].Diabetologia.1997(11)
  • 3Yuan M,Konstantopoulos N,Lee J,et al.Reversal of obesity-and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta[].Science.2001
  • 4Freeman DJ,Norrie J,Caslake MJ,et al.C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study[].Diabetes.2002
  • 5Kim HJ,Higashimori T,Park SY,et al.Differential effects of interleukin-6 and-10 on skeletal muscle and liver insulin action in vivo[].Diabetes.2004

同被引文献4

引证文献2

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部